Biotechnology
Health
Therapy
Seres Therapeutics
$3.019876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.09 (-2.90%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell MCRB and other stocks, options, ETFs, and crypto commission-free!
About MCRB
Seres Therapeutics, Inc. operates a microbiome therapeutics platform company, which engages in the development of biological drugs. The firm creates medicines using live bacteria to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. Read More It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A. Berry and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Employees
145
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
127.39M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
456.88K
High Today
$3.12
Low Today
$2.93
Open Price
$3.09
Volume
432.59K
52 Week High
$9.26
52 Week Low
$2.02
Collections
Biotechnology
Health
Therapy
Technology
2015 IPO
US
Price Paid on Robinhood
67% Lower
Right Now
52 Week Low
$4.42
Average Price Paid
$9.26
52 Week High
$9.75
Analyst Ratings
86%
of 7 ratings
Buy
86%
Hold
14%
Sell
0%
MCRB Earnings
-$0.76
-$0.63
-$0.51
-$0.38
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, Pre-Market